Basilea Pharmaceutica AG
BPMUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $121 | $60 | $85 | $54 |
| Short-Term Investments | $0 | $52 | $0 | $95 |
| Receivables | $57 | $28 | $57 | $25 |
| Inventory | $32 | $26 | $24 | $23 |
| Other Curr. Assets | $12 | $38 | $10 | $45 |
| Total Curr. Assets | $221 | $152 | $175 | $241 |
| Property Plant & Equip (Net) | $19 | $21 | $22 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $23 | -$93 |
| Tax Assets | $17 | $0 | -$23 | $95 |
| Other NC Assets | $0 | $0 | $23 | $0 |
| Total NC Assets | $37 | $21 | $45 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $258 | $173 | $221 | $247 |
| Liabilities | – | – | – | – |
| Payables | $11 | $6 | $0 | $11 |
| Short-Term Debt | $2 | $18 | $39 | $124 |
| Tax Payable | $0 | $0 | $1 | $2 |
| Deferred Revenue | $0 | $0 | $27 | $34 |
| Other Curr. Liab. | $32 | $24 | $7 | $4 |
| Total Curr. Liab. | $46 | $48 | $75 | $174 |
| LT Debt | $110 | $111 | $148 | $95 |
| Deferred Rev, NC | $11 | $9 | $11 | $12 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $15 | $33 | $25 |
| Total NC Liab. | $131 | $136 | $191 | $131 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $16 | $18 | $18 | $1 |
| Total Liabilities | $177 | $183 | $266 | $306 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $10 | $4 | $0 |
| Common Stock | $13 | $13 | $13 | $13 |
| Retained Earnings | -$923 | -$1,001 | -$1,035 | -$1,023 |
| AOCI | -$5 | -$10 | -$4 | -$22 |
| Other Equity | $996 | $978 | $977 | $973 |
| Total Equity | $81 | -$10 | -$45 | -$59 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $258 | $173 | $221 | $247 |
| Net Debt | -$9 | $69 | $102 | $165 |